Clopidogrel: all 338 studies that test it

Page 4 of 4. Open to participants first (32), then studies with results posted, then the rest; newest registration first within each.

• Food Study of Clopidogrel Bisulfate Tablets 75 mg to Plavix® Tablets 75 mgCompletedNCT00650169Phase 1
• Fasting Study of Clopidogrel Bisulfate Tablets 75 mg to Plavix® Tablets 75 mgCompletedNCT00648947Phase 1
• Effect of Plavix on NO (Nitrogen Monoxide) Production of the Endothelial FunctionCompletedNCT00648453Phase 4
• GRAVITAS: Gauging Responsiveness With A VerifyNow Assay-Impact On Thrombosis And SafetyCompletedNCT00645918Not applicable
• Abrupt Versus Tapered Interruption of Chronic Clopidogrel Therapy After DES ImplantationTerminatedNCT00640679Phase 4
• Doubling the Maintenance Dose of Clopidogrel in Patients With High On-Clopidogrel Platelet ReactivityTerminatedNCT00638326Phase 3
• The Comparison of Effects Between Increased Dose of Clopidogrel and Addition of CilostazolCompletedNCT00620646Not applicable
• Clinical Management of Antiplatelet Drug Resistance in Patients With Drug Eluting Coronary StentsWithdrawnNCT00589862Phase 4
• Platelet Function Assessment for Atherothrombotic PatientsStatus unknownNCT00513149Phase 4
• Association of Clopidogrel Therapy and Stent ThrombosisCompletedNCT00484926Phase 4
• Clopidogrel Reloading in Clopidogrel Resistant Patients With ACSCompletedNCT00444132Phase 3
• H2 Haplotype and CYP3As Polymorphisms and the Antiplatelet Response to ClopidogrelCompletedNCT00433784Phase 4
• Clopidogrel Only Before Percutaneous Coronary Intervention or Before Every Coronarography?CompletedNCT00432120Phase 3
• Role of Plavix in Hemorrhagic and Ischemic Complications of Catheterization.TerminatedNCT00421252Phase 4
• The Optimal Duration of Dual Antiplatelet Therapy After Implantation of Endeavor StentCompletedNCT00418860Not applicable
• Influence of CYP2C19 Genetic Variants on Clopidogrel in Healthy SubjectsCompletedNCT00413608Phase 1
• Clopidogrel Maintaining Dosage in Acute Coronary Syndrome After Drug Eluting Stent ImplantationCompletedNCT00404053Phase 4
• Safety and Efficacy of Clopidogrel for Cerebral Infarction TreatmentCompletedNCT00386191Phase 4
• CIPAMI-Study: Clopidogrel Administered Prehospital to Improve Primary PCI in Patients With Acute Myocardial InfarctionCompletedNCT00372216Phase 3
• ALBION "Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis"CompletedNCT00360386Phase 2
• Clopidogrel and Aspirin Together: The Effect on C-Reactive Protein TrialCompletedNCT00343876Phase 4
• Preoperative Aspirin and Postoperative Antiplatelets in Coronary Artery Bypass Grafting: The PAPA CABG StudyCompletedNCT00330772Phase 3
• Efficacy and Safety in Patients With Acute Coronary Syndrome Without ST-Segment ElevationCompletedNCT00325390Phase 3
• Mixed Antagonist of Serotonin for Claudication Optimal TherapyCompletedNCT00300339Phase 2
• PROCLAIM: Study Examining Effects of Clopidogrel Compared to Placebo on Inflammation in Subjects With Metabolic SyndromeCompletedNCT00296803Phase 4
• Optimum Platelet Inhibition After Coronary Bypass SurgeryCompletedNCT00262275Not applicable
• Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE W)TerminatedNCT00243178Phase 3
• Efficacy and Safety of Adding Clopidogrel to Aspirin or Use of Metoprolol in Myocardial InfarctionCompletedNCT00222573Phase 4
• Aspirin Non-responsiveness and Clopidogrel Endpoint Trial.CompletedNCT00222261Phase 4
• The Effects of Physical Training, ASA (Aspirin), and Clopidogrel on the Walking Capacity of Patients With Stage II Peripheral Arterial Disease (PAD)CompletedNCT00189618Phase 4
• CASPAR : Clopidogrel and Acetyl Salicylic Acid in Bypass Surgery for Peripheral ARterial DiseaseCompletedNCT00174759Phase 3
• Mirror Trial - Follow-Up Management of Peripheral Arterial Intervention With ClopidogrelCompletedNCT00163267Phase 2/3
• 75 or 150 mg Clopidogrel Maintenance Doses Following PCI (ISAR-CHOICE-2)CompletedNCT00140465Phase 4
• Platelet Aggregation Inhibition in Children on Clopidogrel (PICOLO)CompletedNCT00115375Phase 2
• A Study of Aspirin and Clopidogrel in Patients With Idiopathic Pulmonary Arterial HypertensionCompletedNCT00105209Phase 2
• Secondary Prevention of Small Subcortical Strokes TrialCompletedNCT00059306Phase 3
• Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA)CompletedNCT00050817Phase 3
• The Inhibition of Platelet Antiaggregating Activity of Clopidogrel by Atorvastatin Detected by Erythromycin Breath Test: a Metabolic Inhibition of Hepatic Cytochrome P450-3AStatus unknownNCT00004564Not applicable

← Clopidogrel overview